The first "show" of this month was successful, and more overseas high-quality projects continue to be wonderful

  On July 15 at 15:00, the fifth session of the Inno-Express series of online roadshow was organized by the National Technology Transfer Eastern Center, Shanghai International Technology Exchange Market, ZhiFanYeMao, Shanghai Oriental Institute of Medical Innovation, directed by Shanghai Municipal Science and Technology Commission, Shanghai Minhang District Science and Technology Commission, and supported by Shanghai Nan Hongqiao Investment and Development Co. -- The biomedical special event was successfully held. As a warm-up activity for the 2020 Pujiang Innovation Forum and the Global Technology Transfer Conference, the event cooperated with Minhang District, where the pharmaceutical industry is concentrated, to promote global biomedical technology achievements and enhance the influence of the industry by joining hands with high quality and professional international technology transfer service providers, and provide an opportunity for quality technology projects to be showcased at the Global Technology Transfer Conference.

After the roadshow, Mr. Jinzhe Fu, Deputy Director of Hongqiao International Trade Development Center (HITDC), first introduced the Hongqiao International Import Commodities Exhibition and Trade Center and welcomed global quality teams and companies to set up in Hongqiao. Afterwards, Shanghai International Technology Exchange Market (SITEM) and ChipFanYeMao conducted background introduction respectively.

The roadshow used a bilingual approach to select three innovative projects from around the world to showcase around the hot topic of biomedicine. Each project demonstrated its advantages in related fields to the participants: a drug from the United States for the treatment of neurodegenerative diseases can effectively inhibit neuroinflammation caused by imbalance of intestinal flora, and can deal with psychiatric diseases caused by DNA hypomethylation, which is better than drugs already in development to prevent or treat Alzheimer's disease; Norway's Doppler ultrasound technology for continuous direct measurement of cerebral blood flow. Provides direct, non-invasive and continuous monitoring of cerebral blood flow in premature or critically ill infants. Used to monitor the infant's cerebral circulation during resuscitation and intensive care treatment, providing timely cardiac intervention and reducing the risk of neonatal mortality and neurodevelopmental impairment; Italian artificial intelligence technology for medical reporting and health data analysis intelligently analyzes the patient's physiological parameters, analyzes and extracts meaning from raw medical data, and transforms medical reports and health data into easy-to-understand, interactive designs. Personalized explanations and health guidance. The projects all received positive attention from the participants.

It is worth mentioning that two experts in the field were invited to review the project and ask questions in real time, including Dr. Xiaolong Li, a World Bank Asia Pacific project expert and biomedical reviewer from the Ministry of Science and Technology, and Dr. Pan Xian, a geneticist from Fudan University. During the roadshow, both of them gave high praise to the Norwegian Doppler ultrasound technology, recognizing its strong technical level, mature products, large market demand and high degree of industrialization, and will continue to pay attention to its future development. This event has received a lot of positive attention in the field, and industry professionals from various localities and organizations have interacted with each other during the roadshow. This month, we will continue to work with domestic and foreign service organizations to bring more exciting projects to enterprises in various industries, so please look forward to it.

en_USEN
Scroll to Top